Patients who have Tacrolimus trough level resulted as 2 ng/mg at the baseline.
Patients who are on steroid therapy due to positive result of acute rejection test before the baseline.
Patients who have received a transplant besides liver.
Patients who are allergic to IP or macrolide compounds.
Patients who are on cyclosporine, bosentan, or potassium sparing diuretic.
Patients with genetic diseases such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption.
Pregnant or lactating women.
Patients not willing to adhere to study procedures/treatments.

NCT02882113_exc_T1
Measurement
Tacrolimus
NCT02882113_exc_T2
Value
2 ng/mg
NCT02882113_exc_T3
Drug
steroid
NCT02882113_exc_T4
Measurement
acute rejection test
NCT02882113_exc_T5
Value
positive
NCT02882113_exc_T6
Procedure
transplant
NCT02882113_exc_T7
Qualifier
liver
NCT02882113_exc_T8
Condition
allergic
NCT02882113_exc_T10
Drug
IP
NCT02882113_exc_T11
Scope
IP or macrolide compounds
NCT02882113_exc_T9
Drug
macrolide
NCT02882113_exc_T12
Drug
cyclosporine
NCT02882113_exc_T13
Drug
bosentan
NCT02882113_exc_T14
Drug
potassium sparing diuretic
NCT02882113_exc_T15
Condition
genetic diseases
NCT02882113_exc_T16
Condition
galactose intolerance
NCT02882113_exc_T17
Condition
Lapp lactase deficiency
NCT02882113_exc_T18
Condition
glucose-galactose malabsorption
NCT02882113_exc_T19
Scope
galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption